Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Lung Cancer Surgery Industry Expected To Reach By 2029, Starting From 2025 Levels?
The market for lung cancer surgery has demonstrated robust expansion recently. This market is projected to expand from $5.07 billion in 2024 to $5.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to its historical growth include a high prevalence of smoking, an increase in lung cancer cases, the expansion of hospital infrastructure, broader insurance coverage, and an enhancement in surgeon expertise.
The lung cancer surgery market size is projected to experience consistent expansion in the coming years. It is anticipated to reach $6.43 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 4.8%. This anticipated growth throughout the forecast period stems from factors such as the world’s aging populace, an increase in non-small cell lung cancer occurrences, enhanced awareness in developing nations, a significant rise in robotic surgery platforms, and greater investment in cancer treatment. Key trends expected during the forecast timeframe encompass robotic-assisted thoracic surgery, the application of augmented reality within surgical procedures, 3-dimensional printing utilized for surgical simulation, artificial intelligence employed for surgical planning, and the advancement of smart surgical instruments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Lung Cancer Surgery Industry?
The rise in lung cancer cases is projected to drive forward the expansion of the lung cancer surgery market. Lung cancer is characterized by the unchecked proliferation of abnormal cells within one or both lungs, disrupting normal respiratory function. This heightened occurrence of lung cancer stems from extended exposure to air pollution, specifically excellent particulate matter; these minute particles can delve deep into the lungs, initiating inflammation, cellular harm, and mutations that pave the way for cancer development. Lung cancer surgery plays a crucial role in lowering lung cancer-associated fatalities by facilitating the early excision of malignant tumors before their dissemination or progression. For example, in June 2025, the Centers for Disease Control and Prevention, a US-based federal government agency, reported that in 2023, lung cancer led to 131,584 deaths in the United States, following 218,893 newly reported cases in 2022. Consequently, the growing prevalence of lung cancer is fueling the growth of the lung cancer surgery market.
What Are The Primary Types Of Segments Analyzed In The Lung Cancer Surgery Market?
The lung cancer surgery market covered in this report is segmented –
1) By Type: Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users
Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
Which Trends Are Impacting The Lung Cancer Surgery Market?
Major enterprises operating within the lung cancer surgery domain are prioritizing the creation of cutting-edge technologies, such as robotic-assisted interventions, to refine surgical accuracy, shorten recovery periods, and improve patient health outcomes. Robotic-assisted surgeries are defined as minimally invasive operations carried out using robotic systems guided by surgeons to heighten precision, reduce adverse events, and facilitate better patient recuperation. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology firm, publicized the regulatory approval of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers superior reach and stability to access small, challenging-to-reach lung nodules, thereby enhancing the capacity for earlier lung cancer diagnosis. Its sophisticated maneuverability and integration with imaging technologies allow for more precise biopsies while simultaneously minimizing patient distress. Designed to broaden procedural scope and optimize workflow, the platform fosters increased clinical assurance and uniformity across a wider array of bronchoscopic procedures.
Who Are The Top Performing Companies In The Lung Cancer Surgery Market In Recent Years?
Major companies operating in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report
What Are The Regional Market Dynamics Impacting The Lung Cancer Surgery Industry?
North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Lung Cancer Surgery Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp
Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2025, By The Business Research Company
Lung Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Non Small Cell Lung Cancer Nsclc Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
